61
Participants
Start Date
June 30, 2016
Primary Completion Date
May 15, 2019
Study Completion Date
May 15, 2019
IGSC 20%
Weekly administration of IGSC 20% via intravenous infusion
Royal Melbourne Hospital, Parkville
Wesley Medical Research, Auchenflower
The Children's Memorial Health Institute, Warsaw
Hospital Universitario Reina Sofia, Córdoba
Universitätsklinikum Hamburg-Eppendorf, Hamburg
Hospital Clinico San Carlos, Madrid
Hospital 12 Octubre, Madrid
CHU de Montpellier, Montpellier
Hospital Virgen del Rocio, Seville
Klinikum Dortmund gGmbH, Dortmund
University Hospital, Hradec Králové
Asklepios Klinik Sankt Augustin, Sankt Augustin
University Hospital of Mainz, Mainz
Children's Hospital at Municipal Hospital St. Georg, Leipzig
United St Istvan and St Laszlo Hospital, Budapest
Josa Andras County Hospital, Nyiregyháza
Hospital Universitario Vall d'Hebron, Barcelona
Vall d'Hebron University Hospital, Barcelona
Hospital Universitari Sant Joan de Déu, Barcelona
Stockholm, Stockholm
Addenbrooke's Hospital, Cambridge
St Bartholomew's Hospital, London
Derriford Hospital, Plymouth
Lead Sponsor
Grifols Therapeutics LLC
INDUSTRY